IFAPP

The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine

National Member Associations

IFAPP consists of the leading professional associations in pharmaceutical medicine and drug development.

Education

Worldwide Development and Professional Certification

Communication

Excellent Global Communication Since 1975

Collaborations

IFAPP collaborates and coordinates with key players in the fields of pharmaceutical medicine and medicines development

Certification Working Group

CCWG works collaboratively in the development and delivery of relevant and recognised education and training in PM/MDS for the benefit of IFAPP’s professional membership.

Education and Certification Working Group

Chair

Birka Lehmann
Education en certi (002)

Education and Certification Work Group

The Education and Certification Working Group (ECWG) will work on the delivery of education and training courses for professionals within the field of Pharmaceutical Medicine/Medicines Development Sciences (PM/MDS).

Scope

The scope of the Education and Certification WG is based on IFAPP’s overall strategy and mission to promote Pharmaceutical Medicine with regard to the discovery, development, research and use of medicines. As a basis for training programmes, the PharmaTrain1 Syllabus v2.0 (reference) will be used.

 

Objectives 

  • By working closely with other IFAPP WGs and external bodies such as nationally and internationally operating bodies (e.g. FPM2, CIOMS3) and also by involving senior experts in PM engaged in IFAPP (e.g. Past Presidents, GFMD4) and Individual Affiliates, ECWG will enhance the discipline of PM by attracting more skilled and well trained people from different disciplines and enabling them to develop effective and safer drugs for the patients.
  • ECWG will interact closely with its National Member Associations in the various regions in the world and support region-specific affordable training courses and will make every attempt to endorse and ensure their recognition and certification on either a national, regional or, if possible, on a global level.
  • New and affordable online learning possibilities will be explored and endorsed so that IFAPP's membership in many countries of the world can profit from these.
  • ECWG will foster the recognition of educational programmes in order to advance the discipline of PM.
  • Latest requirements from medicines regulatory agencies  (e.g. EMA, FDA, national governmental bodies) will be taken into account and IFAPP will thrive to ensure the most up-to-date contents in these educational programmes.


Measures

Concrete measures will be laid down in a work plan drafted by the group and reviewed on an annual basis.

 

1 PharmaTrain https://www.pharmatrain.eu/news.php; https://ifapp.org/about/pharmatrain-syllabus
2 FPM               Faculty of Pharmaceutical Medicine of the Royal Colleges of the United Kingdom
3 CIOMS           Council for International Organisations of Medical Sciences
4 GFMD            Global Fellow in Medicines Development

 

Click here for the Call for Applications on the IFAPP News page.

IFAPP Advertentie (2)